Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. - Test2 - elhamkhani - TriplyDB

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

http://www.wikidata.org/entity/Q35923351

about

Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.Opioid overdose and naloxone education in a substance use disorder treatment program.Injection drug use and overdose among young adults who use prescription opioids non-medically.Increase in Drug Overdose Deaths Involving Fentanyl-Rhode Island, January 2012-March 2014.Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.The opioid overdose epidemic: opportunities for pharmacists Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.PHArmacists' perspective oN the Take hOme naloxone prograM (The PHANTOM Study).Prescription opioid abuse: pharmacists' perspective and response.Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal.Naloxone rescheduling in Australia: Processes, implementation and challenges with supply of naloxone as a 'pharmacist only' over-the-counter medicine.

P2860

Q30824524-6DB44059-30C2-493A-A036-0908F4369942 Q36693441-F44226A6-64E2-46CC-8D0F-359D94D70A59 Q37309608-931CC5F8-C86A-4AF9-8B7C-FB2118939925 Q37352258-CEA92B74-A034-4440-806B-BD0B5BF0C9D9 Q38666466-C96ED93B-A6B2-4841-8011-49B408BEB329 Q38878439-788A7DF6-29B5-4644-B497-AFC02F99B242 Q38978228-4FBC74A7-0226-4F07-BACF-CC9E033E00B5 Q39162151-8EFFCBA6-ABFD-4086-B674-6D709CBAB785 Q40339556-0FF98750-5CE6-4240-8FDC-6691267693BA Q42342841-08B79A4E-9DC0-42BA-AECF-C35B34B6357B Q44344344-4C0D5772-61BF-46DF-9DBE-E033F0906737 Q44620818-8EE2A2B5-8193-42DD-B97F-48ADCFCF1FD1 Q48078165-57FA5328-0CCD-438F-9723-56E44CF10F68 Q48178385-B6B5B5D1-03F4-4EBA-A9AC-52FE284B18C6 Q53328367-53A93D28-22DE-4145-8D79-310C04F4AE4B

P2860

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

http://www.wikidata.org/entity/Q35923351

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

@ast

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

@en

type

label

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

@ast

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

@en

prefLabel

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

@ast

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

@en

P1433

Q35923351-4E564464-F37F-4FC4-B692-7C0CD0C13EF5

P1476

Q35923351-6F9086BE-E9D2-4259-A8B8-9B5D5E566405

P2093

Q35923351-02D62C37-4927-4BB3-8280-3B5F596ECD6B

Q35923351-50D46AD7-5539-414E-A46C-89CE16B934E6

Q35923351-5248D89C-923A-43E0-8384-5697EBCFCB29

Q35923351-879AFE80-130B-4D67-A81D-4C25ED94D882

Q35923351-C40F5686-833C-4209-8ACD-D44B02B2D23A

P2860

Q35923351-043D8AFB-B710-4673-B23C-408C19466CF4

Q35923351-054F4B51-CB2A-4CE7-9308-B64B69585648

Q35923351-0BA20F6C-85AE-4D38-AD4A-28025B7B3BFF

Q35923351-260E703C-14A4-45E1-ACF3-3C330ACE8DD6

Q35923351-289649FB-35D0-40FF-B13E-34FE53557AA4

Q35923351-2E988588-F4A0-445A-BCA9-A0BF2869E256

Q35923351-2FA56710-7682-4675-92CA-FBDD65BC1942

Q35923351-3A82CD1F-6771-4BE2-A679-837F1E0B0CB7

Q35923351-3C87F062-8FDF-42AB-9F95-0B774B011777

Q35923351-3D339D66-F6C7-4591-8997-EA0227101879

P2888

Q35923351-D90AF21C-1604-4925-92B4-C32D8929337A

P304

Q35923351-42DD496E-5E57-48CC-A272-63BE2E45FD8E

P31

Q35923351-FA62CE60-A9D8-434E-A4C4-184D9824C567

P356

Q35923351-1D8C8367-B0D5-4DC5-BAFA-25848F72338C

P478

Q35923351-25146A0F-A318-4674-92C4-EF52DB85AAF9

P577

Q35923351-CB4F104E-FAD2-49DA-94D1-634D9544E946

P5875

Q35923351-F02FEBDB-4018-4A35-B906-9E04D2B7AC34

P6179

Q35923351-56C113F9-705A-4177-AFFF-073F133D8ADF

P698

Q35923351-6F5289BE-48F7-429F-8F94-1D5D514093DC

P932

Q35923351-58D4A426-1B1A-402A-8402-9B113A37B41A

P356

S12954-015-0058-X

P1433

Harm Reduction Journal

P1476

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

@en

P2093

Alexander Y Walley

http://www.w3.org/2001/XMLSchema#string

Corey S Davis

http://www.w3.org/2001/XMLSchema#string

Emily F Dauria

http://www.w3.org/2001/XMLSchema#string

Jeffrey Bratberg

http://www.w3.org/2001/XMLSchema#string

Traci C Green

http://www.w3.org/2001/XMLSchema#string

P2860

Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

Acute heroin overdose.

Birth-cohort trends in lifetime and past-year prescription opioid-use disorder resulting from nonmedical use: results from two national surveys.

Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists

Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective.

Community-based opioid overdose prevention programs providing naloxone - United States, 2010.

Acetyl fentanyl overdose fatalities--Rhode Island, March-May 2013.

Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI

Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.

P2888

s12954-015-0058-x

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12954-015-0058-X

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280870962

http://www.w3.org/2001/XMLSchema#string

P6179

1023799408

http://www.w3.org/2001/XMLSchema#string

P698

26245865

http://www.w3.org/2001/XMLSchema#string

P932

4527253

http://www.w3.org/2001/XMLSchema#string